MTOR and glioblastoma: However, in glioblastoma cells not expressing MGMT, resistance to TMZ was shown to be associated with a PI3K–mediated HOX/stem cell gene signature, and this resistance was reversed by inhibition of the PI3K signalling pathway using the dual pan-class I PI3K/mTOR inhibitor PI-103 [13–15].